Effects of Expiratory Muscle Training Added to Pulmonary Rehabilitation in Patients With Bronchiectasis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorIstanbul Demiroglu Bilim University

About this trial

This randomized, single-blind, parallel-group controlled trial aims to investigate the effects of expiratory muscle training added to standard pulmonary rehabilitation on respiratory muscle strength, pulmonary function, cough effectiveness, exercise capacity, dyspnea perception, and quality of life in patients with non-cystic fibrosis bronchiectasis. Eligible patients aged 18-70 years with stable disease will be randomly assigned to either a pulmonary rehabilitation-only group or a pulmonary rehabilitation combined with expiratory muscle training group. Outcomes will be assessed at baseline and after completion of the intervention period.

Eligibility criteria

Qualifiers

Age between 18 and 70 years

Clinical diagnosis of non-cystic fibrosis bronchiectasis

Stable disease status

Follow-up at the Pulmonary Rehabilitation Unit of University of Health Sciences Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

Disqualifiers

Acute exacerbation within the last 3 months

Diagnosis of cystic fibrosis-related bronchiectasis

Presence of severe cardiac, neurological, or orthopedic diseases that may interfere with exercise training

Cognitive impairment, lack of cooperation, or communication difficulties

Trial design

Treatments tested in this trial

  • pulmonary rehabilitation
  • Expiratory muscle training

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Istanbul Demiroglu Bilim University

Lead sponsor

Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital

Collaborator